Skip to main content
Menu

GSP Neonatal IRT kit

The GSP® Neonatal IRT assay allows the quantitative determination of IRT from dried blood spot specimens, and is intended as an aid in screening for cystic fibrosis.

Feature Specification
Application Newborn Screening

The GSP® Neonatal IRT assay allows the quantitative determination of IRT from dried blood spot specimens, and is intended as an aid in screening for cystic fibrosis.

Product variant
Unit Size: 1 kit
Part #:
3306-001U
For in vitro diagnostic use. This product is only available where licensed in accordance with law. Please contact your local representative for availability.
Request more information

Overview

The diagnosis of cystic fibrosis is often based on the symptoms, which may cause considerable delays in the disease intervention, and evidence indicates that early attention may be important in determining the clinical outcome. The amount of the pancreatic enzyme, immunoreactive trypsin (ogen) (IRT) has been shown to be increased in blood of CF patients especially during the first weeks after birth.

GSP Neonatal IRT assay:

  • Linear calibration curve fitting - improved precision
  • Incubation time 2 h
  • Sensitive, robust DELFIA chemistry for confidence in results
  • All reagents are ready to use
  • The kit contains reagents and plates for 1152 tests (12 plates)

The assay is based on a direct sandwich technique where two monoclonal antibodies bind to different epitopes on the target molecule. The fluorescence signal is proportional to the analyte concentration in the sample.

Specifications

Application
Newborn Screening
Brand
GSP®
Detection Modality
Time-Resolved Fluorescence (TRF)
Disorders
Cystic Fibrosis
Instrument Compatibility
GSP
Quantity
1152 tests
Sample Type
Dried blood spots
Technology
DELFIA
Unit Size
1 kit

Resources

Are you looking for resources, click on the resource type to explore further.

Scroll Icon

Revvity AI Assistant Beta